Business Wire

31. Pleno Inc. Announces First Commercial Agreement With Slopes Bio, Inc 8/6/2025

    Pleno Inc., an early-stage biotechnology company developing innovative multi-omic solutions, and Slopes Bio, Inc., an innovative high-complexity accredited laboratory, today announced a comprehensive commercial agreement in biological target detection and personalized health.

32. LabConnect Deploys Sapio LIMS Across Global Operations 8/6/2025

    Sapio Sciences, the science-awareTM lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect.

33. Agilent Expands The Dako Omnis Family With Three New Models To Meet Evolving Pathology Lab Needs 8/4/2025

    Agilent Technologies Inc. today announced the introduction of its Dako Omnis family of instruments with three new models—Agilent Dako Omnis 110, 165, and 165 Duo—designed to meet the evolving needs of pathology laboratories of all sizes.

34. NeoGenomics Launches PanTracer LBx, Expanding Access To Comprehensive Genomic Profiling With Liquid Biopsy 7/30/2025

    NeoGenomics, Inc., a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer LBx, a blood-based comprehensive genomic profiling (CGP) test, expanding the company’s PanTracer portfolio.

35. Quansys Biosciences Launches Q-View Imager Plus: Delivering Reproducible, High-Impact ELISA Data With Ease 7/29/2025

    Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View Imager Plus, a next-generation imaging device designed to deliver reproducible, high-resolution ELISA results with streamlined workflows.

36. hc1 And Shadowbox Partner To Close Patient Care Gaps With Optimized Diagnostic Laboratory Testing 7/29/2025

    hc1, a leader in transforming actionable lab data into valuable insights that enable healthcare systems to close gaps in patient care and improve financial performance, and Shadowbox, an innovator in automation for independent labs, have announced a strategic partnership.

37. Thermo Fisher Scientific Showcases Diagnostics Solutions Designed To Meet Evolving Global Healthcare Demands At ADLM 2025 7/28/2025

    Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill.

38. Idengene SA To Bring Contextual Genomics' Revolutionary Cancer Genomic Test Find-It To Brazil 11/9/2017

    Brazilian diagnostics company Idengene SA has partnered with leading Canadian cancer genomics company Contextual Genomics to bring Find-It™, a potentially revolutionary genomic test, to Brazil. Idengene will offer Find-It™ at its laboratory in Brazil to patients diagnosed with cancer

39. New Benchtop Centrifuge Incorporates Hybrid Rotor For Application Flexibility 2/4/2016

    Clinical and life science researchers can now benefit from a new benchtop centrifuge that features a unique 2-in-1 hybrid rotor that has interchangeable fixed-angle and swinging buckets to facilitate quick and convenient switching between applications

40. First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015

    The first patient with atrial fibrillation (AF) has been enrolled in the global RE-CIRCUIT™ study.⁴ The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa^®) during ablation procedures compared to warfarin.¹ Results from the RE-CIRCUIT™ study are expected during 2016